Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis - Aix-Marseille Université Access content directly
Journal Articles Travel Medicine and Infectious Disease Year : 2020

Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis

Matthieu Bardou
  • Function : Author
Cyril Berenger
  • Function : Author

Abstract

Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre-including this research content-immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
Fichier principal
Vignette du fichier
main.pdf (2.57 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03138793 , version 1 (11-02-2021)

Licence

Attribution - NonCommercial - NoDerivatives

Identifiers

Cite

Jean-Christophe J.-C. Lagier, Matthieu Million, Philippe Gautret, Philippe Colson, Sébastien Cortaredona, et al.. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Medicine and Infectious Disease, 2020, 36, pp.101791. ⟨10.1016/j.tmaid.2020.101791⟩. ⟨hal-03138793⟩
194 View
84 Download

Altmetric

Share

Gmail Facebook X LinkedIn More